Lumentum Falls Despite $115 Billion Marvell Takeover Confirmation

Confirmed Deal, Falling Stock

Lumentum Holdings was trading at $745.66 as of 2 November 2026 at 16:02 UTC, down -11.23% on the session — the second sharp move in less than a week on the same story. On 28 October, the stock surged roughly 15% in after-hours trading after a Bloomberg report said Marvell was in advanced talks to acquire the optical components maker. On 2 November, Marvell confirmed the deal with unanimous approval from both boards, announcing an all-stock transaction with an implied enterprise value of $115 billion.

The structure is the problem. Lumentum shareholders will receive 4.5 Marvell shares for each share they own. Because the exchange ratio is fixed rather than the dollar value, the consideration moves with Marvell's stock price. Marvell shares fell sharply on the announcement, and analysis suggests that slide has pulled the effective payout from the headline figure of $1,132 per share to a materially lower level — with Lumentum trading roughly 10% below even that reduced implied value. The gap coincided with a closing timeline that does not extend to completion until the first half of 2028, subject to shareholder and regulatory approvals.

The companies said the combined addressable market would reach $550 billion, and Marvell's chairman and CEO Matt Murphy said in the announcement that "AI infrastructure is undergoing a fundamental architectural shift toward optical connectivity, creating an opportunity that comes along once in a generation." Marvell also expects more than $1 billion in annual run-rate cost synergies and projects the deal to be accretive to non-GAAP earnings per share within one year of closing.

Lumentum also reported adjusted earnings of $4.57 per share on revenue of $1.26 billion in its fiscal first quarter, up 136% from a year earlier, with forward guidance above expectations. Neither the results nor the guidance arrested the decline, as the mechanics of the all-stock deal dominated trading.

A 28% Monthly Slide Frames the Damage

The session's drop extends a brutal stretch for Lumentum shareholders. Over the past month, the stock has shed -28.74%, with the one-month high reaching $1,140.61 and the low at $735.06.

The core tension is straightforward: a fixed share-ratio deal in a falling acquirer is worth less each day the acquirer's stock drops. With closing not expected until the first half of 2028, a persistent discount to the implied deal value has opened up, and strong underlying results have not been enough to close it.

Shareholder Vote and Regulatory Clock Ahead

The next formal milestones are the shareholder votes and regulatory clearances required before the deal can close in the first half of 2028. Until those processes advance, Lumentum's price is likely to trade as a function of Marvell's share price and the market's evolving read on deal-completion probability.

A sustained recovery in Marvell shares would mechanically lift the implied consideration and could narrow the discount at which Lumentum currently trades. A further decline in Marvell, or any signal of regulatory friction, would widen it.